Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Amenable to Skipping Exon 45
.
Show all posts
Showing posts with label
Amenable to Skipping Exon 45
.
Show all posts
Monday, March 1, 2021
FDA Approves Amondys 45 (casimersen) Injection for the Treatment of Duchenne Muscular Dystrophy (DMD) in Patients Amenable to Skipping Exon 45
›
In continuation of my update on antisense oligonucleotides Sarepta Therapeutics, Inc. the leader in precision genetic medicine for rare d...
›
Home
View web version
